CA Stock MarketDetailed Quotes

APLI Appili Therapeutics Inc

Watchlist
  • 0.040
  • +0.005+14.29%
15min DelayMarket Closed Nov 26 16:00 ET
4.85MMarket Cap-1333P/E (TTM)

Appili Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
93.47%-132.08K
75.59%-2.46M
58.83%-456.69K
126.45%253.24K
92.34%-237.14K
59.01%-2.02M
47.08%-10.1M
71.29%-1.11M
83.71%-957.3K
-20.01%-3.09M
Net income from continuing operations
-2.35%-1.58M
59.09%-3.78M
58.53%-1.1M
94.18%-152.34K
40.39%-976.56K
33.39%-1.55M
63.20%-9.24M
20.18%-2.66M
19.13%-2.62M
85.34%-1.64M
Operating gains losses
136.82%52.61K
-108.81%-35.54K
153.88%113.87K
-103.77%-102.51K
-61.69%95.99K
-190.32%-142.89K
801.86%403.29K
140.86%44.85K
-221.39%-50.31K
2,504.40%250.54K
Depreciation and amortization
-2.24%3.37K
118.03%13.66K
108.44%3.39K
119.33%3.39K
122.64%3.44K
122.21%3.44K
-50.44%6.27K
-52.29%1.62K
-46.95%1.55K
-51.87%1.55K
Remuneration paid in stock
-45.70%80.01K
-78.13%191.35K
-97.31%10.05K
-91.08%17.7K
-90.49%16.25K
11.39%147.35K
-57.10%875.12K
-1.76%373.49K
-69.91%198.53K
-69.80%170.81K
Other non cashItems
222.72%1.23M
-55.70%485.58K
-90.02%84.17K
29.27%158.07K
-226.20%-138.14K
120.36%381.47K
-29.51%1.1M
-26.76%843.04K
-49.67%122.28K
-131.09%-42.35K
Change In working capital
109.92%85.74K
120.44%661.44K
50.94%435.31K
-76.34%328.92K
141.49%761.87K
71.91%-864.66K
-230.10%-3.24M
114.75%288.41K
138.78%1.39M
-123.29%-1.84M
-Change in receivables
31.87%-615K
-177.56%-752.55K
-116.11%-71.67K
-17.39%199.01K
680.77%22.78K
-420.47%-902.67K
228.83%970.29K
41.28%444.8K
221.02%240.91K
-99.65%2.92K
-Change in prepaid assets
238.54%75.73K
181.31%38.67K
-26.76%37.41K
-107.00%-5.46K
-36.58%61.39K
80.01%-54.67K
-117.78%-47.55K
-5.84%51.07K
-16.32%78.07K
152.89%96.8K
-Change in payables and accrued expense
574.42%625.01K
133.07%1.38M
326.34%469.57K
-87.36%135.38K
135.00%677.7K
103.00%92.67K
-316.08%-4.16M
91.07%-207.46K
148.39%1.07M
-132.44%-1.94M
Cash from discontinued investing activities
Operating cash flow
93.47%-132.08K
75.59%-2.46M
58.83%-456.69K
126.45%253.24K
92.34%-237.14K
59.01%-2.02M
47.08%-10.1M
71.29%-1.11M
83.71%-957.3K
-20.01%-3.09M
Investing cash flow
Cash flow from continuing investing activities
0
-815.37%-29.06K
109.80%654
0
0
-897.77%-29.72K
-100.06%-3.18K
-923.06%-6.68K
0
-102.53%-225
Net PPE purchase and sale
--0
-815.37%-29.06K
109.80%654
--0
--0
-897.77%-29.72K
---3.18K
-923.06%-6.68K
--0
79.43%-225
Cash from discontinued investing activities
Investing cash flow
--0
-815.37%-29.06K
109.80%654
--0
--0
-897.77%-29.72K
-100.06%-3.18K
-923.06%-6.68K
--0
-102.53%-225
Financing cash flow
Cash flow from continuing financing activities
214.59%338.43K
-97.93%122.05K
-102.38%-51.37K
-8.63%-45.88K
364.29%111.72K
-97.20%107.58K
-38.23%5.91M
103.32%2.16M
-100.80%-42.24K
-101.30%-42.27K
Net issuance payments of debt
181.79%357.24K
-91.57%203.58K
-101.02%-25.32K
-29.49%-28.1K
717.22%130.22K
718.41%126.78K
-36.95%2.41M
78.87%2.48M
97.87%-21.7K
-100.61%-21.1K
Net common stock issuance
----
--0
--0
--0
----
----
-39.86%3.21M
--0
--0
--0
Cash dividends paid
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
----
--0
--0
--0
----
----
-24.36%1.29M
--0
--0
--0
Interest paid (cash flow from financing activities)
2.01%-18.81K
13.02%-72.52K
14.27%-17.04K
13.41%-17.78K
12.63%-18.5K
11.89%-19.2K
10.35%-83.38K
11.24%-19.88K
10.62%-20.54K
10.06%-21.18K
Net other financing activities
----
99.02%-9.01K
----
----
----
----
24.10%-922.61K
0.38%-300.65K
--0
--0
Cash from discontinued financing activities
Financing cash flow
214.59%338.43K
-97.93%122.05K
-102.38%-51.37K
-8.63%-45.88K
364.29%111.72K
-97.20%107.58K
-38.23%5.91M
103.32%2.16M
-100.80%-42.24K
-101.30%-42.27K
Net cash flow
Beginning cash position
-96.17%94.49K
-63.00%2.47M
-57.76%602.88K
-83.69%395.62K
-90.63%520.59K
-63.00%2.47M
-39.76%6.66M
-84.77%1.43M
-75.71%2.43M
-40.30%5.55M
Current changes in cash
110.60%206.35K
43.44%-2.37M
-148.73%-507.4K
120.75%207.36K
96.00%-125.42K
-77.26%-1.95M
5.89%-4.19M
137.17%1.04M
-70.00%-999.54K
-551.50%-3.14M
Effect of exchange rate changes
-39.13%420
100.85%54
60.98%-988
-106.68%-96
-94.53%448
105.12%690
-111.23%-6.38K
-102.69%-2.53K
105.90%1.44K
165.34%8.19K
End cash Position
-42.13%301.27K
-96.17%94.49K
-96.17%94.49K
-57.76%602.88K
-83.69%395.62K
-90.63%520.59K
-63.00%2.47M
-63.00%2.47M
-84.77%1.43M
-75.71%2.43M
Free cash from
93.57%-132.08K
75.31%-2.49M
58.95%-456.69K
126.45%253.24K
92.34%-237.14K
58.41%-2.05M
47.06%-10.1M
71.20%-1.11M
83.71%-957.3K
-19.96%-3.09M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 93.47%-132.08K75.59%-2.46M58.83%-456.69K126.45%253.24K92.34%-237.14K59.01%-2.02M47.08%-10.1M71.29%-1.11M83.71%-957.3K-20.01%-3.09M
Net income from continuing operations -2.35%-1.58M59.09%-3.78M58.53%-1.1M94.18%-152.34K40.39%-976.56K33.39%-1.55M63.20%-9.24M20.18%-2.66M19.13%-2.62M85.34%-1.64M
Operating gains losses 136.82%52.61K-108.81%-35.54K153.88%113.87K-103.77%-102.51K-61.69%95.99K-190.32%-142.89K801.86%403.29K140.86%44.85K-221.39%-50.31K2,504.40%250.54K
Depreciation and amortization -2.24%3.37K118.03%13.66K108.44%3.39K119.33%3.39K122.64%3.44K122.21%3.44K-50.44%6.27K-52.29%1.62K-46.95%1.55K-51.87%1.55K
Remuneration paid in stock -45.70%80.01K-78.13%191.35K-97.31%10.05K-91.08%17.7K-90.49%16.25K11.39%147.35K-57.10%875.12K-1.76%373.49K-69.91%198.53K-69.80%170.81K
Other non cashItems 222.72%1.23M-55.70%485.58K-90.02%84.17K29.27%158.07K-226.20%-138.14K120.36%381.47K-29.51%1.1M-26.76%843.04K-49.67%122.28K-131.09%-42.35K
Change In working capital 109.92%85.74K120.44%661.44K50.94%435.31K-76.34%328.92K141.49%761.87K71.91%-864.66K-230.10%-3.24M114.75%288.41K138.78%1.39M-123.29%-1.84M
-Change in receivables 31.87%-615K-177.56%-752.55K-116.11%-71.67K-17.39%199.01K680.77%22.78K-420.47%-902.67K228.83%970.29K41.28%444.8K221.02%240.91K-99.65%2.92K
-Change in prepaid assets 238.54%75.73K181.31%38.67K-26.76%37.41K-107.00%-5.46K-36.58%61.39K80.01%-54.67K-117.78%-47.55K-5.84%51.07K-16.32%78.07K152.89%96.8K
-Change in payables and accrued expense 574.42%625.01K133.07%1.38M326.34%469.57K-87.36%135.38K135.00%677.7K103.00%92.67K-316.08%-4.16M91.07%-207.46K148.39%1.07M-132.44%-1.94M
Cash from discontinued investing activities
Operating cash flow 93.47%-132.08K75.59%-2.46M58.83%-456.69K126.45%253.24K92.34%-237.14K59.01%-2.02M47.08%-10.1M71.29%-1.11M83.71%-957.3K-20.01%-3.09M
Investing cash flow
Cash flow from continuing investing activities 0-815.37%-29.06K109.80%65400-897.77%-29.72K-100.06%-3.18K-923.06%-6.68K0-102.53%-225
Net PPE purchase and sale --0-815.37%-29.06K109.80%654--0--0-897.77%-29.72K---3.18K-923.06%-6.68K--079.43%-225
Cash from discontinued investing activities
Investing cash flow --0-815.37%-29.06K109.80%654--0--0-897.77%-29.72K-100.06%-3.18K-923.06%-6.68K--0-102.53%-225
Financing cash flow
Cash flow from continuing financing activities 214.59%338.43K-97.93%122.05K-102.38%-51.37K-8.63%-45.88K364.29%111.72K-97.20%107.58K-38.23%5.91M103.32%2.16M-100.80%-42.24K-101.30%-42.27K
Net issuance payments of debt 181.79%357.24K-91.57%203.58K-101.02%-25.32K-29.49%-28.1K717.22%130.22K718.41%126.78K-36.95%2.41M78.87%2.48M97.87%-21.7K-100.61%-21.1K
Net common stock issuance ------0--0--0---------39.86%3.21M--0--0--0
Cash dividends paid --0--0--0--0--0--0--0--0--0--0
Proceeds from stock option exercised by employees ------0--0--0---------24.36%1.29M--0--0--0
Interest paid (cash flow from financing activities) 2.01%-18.81K13.02%-72.52K14.27%-17.04K13.41%-17.78K12.63%-18.5K11.89%-19.2K10.35%-83.38K11.24%-19.88K10.62%-20.54K10.06%-21.18K
Net other financing activities ----99.02%-9.01K----------------24.10%-922.61K0.38%-300.65K--0--0
Cash from discontinued financing activities
Financing cash flow 214.59%338.43K-97.93%122.05K-102.38%-51.37K-8.63%-45.88K364.29%111.72K-97.20%107.58K-38.23%5.91M103.32%2.16M-100.80%-42.24K-101.30%-42.27K
Net cash flow
Beginning cash position -96.17%94.49K-63.00%2.47M-57.76%602.88K-83.69%395.62K-90.63%520.59K-63.00%2.47M-39.76%6.66M-84.77%1.43M-75.71%2.43M-40.30%5.55M
Current changes in cash 110.60%206.35K43.44%-2.37M-148.73%-507.4K120.75%207.36K96.00%-125.42K-77.26%-1.95M5.89%-4.19M137.17%1.04M-70.00%-999.54K-551.50%-3.14M
Effect of exchange rate changes -39.13%420100.85%5460.98%-988-106.68%-96-94.53%448105.12%690-111.23%-6.38K-102.69%-2.53K105.90%1.44K165.34%8.19K
End cash Position -42.13%301.27K-96.17%94.49K-96.17%94.49K-57.76%602.88K-83.69%395.62K-90.63%520.59K-63.00%2.47M-63.00%2.47M-84.77%1.43M-75.71%2.43M
Free cash from 93.57%-132.08K75.31%-2.49M58.95%-456.69K126.45%253.24K92.34%-237.14K58.41%-2.05M47.06%-10.1M71.20%-1.11M83.71%-957.3K-19.96%-3.09M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data